Regulatory T Cells Decreased With Farm Exposure at Age 6

This article originally appeared here.
Share this content:
Regulatory T Cells Decreased With Farm Exposure at Age 6
Regulatory T Cells Decreased With Farm Exposure at Age 6

TUESDAY, Oct. 18, 2016 (HealthDay News) -- At age 6 years, regulatory T cells (Tregs) are decreased with farm exposure and increased among those with asthma, according to a study published online Oct. 12 in Allergy.

Noting that farm exposure protects against development of allergies early in life, Paul C. Schröder, Ph.D., from the University Children's Hospital in Munich, and colleagues assessed Tregs longitudinally at 4.5 and 6 years in 111 children (56 farm and 55 reference children). Mononuclear cells were cultured unstimulated, with phorbol-12-myristate-13-acetate/ionomycin or lipopolysaccharide (LPS); they were stained for Tregs. Treg/Th1/Th2/Th17-associated cell marker mRNA expression was measured ex vivo. Parents answered detailed questionnaires assessing farm exposures and clinic phenotypes from birth to age 6.

The researchers observed a decrease in Treg percentage before and after stimulation and in FOXP3 mRNA expression ex vivo from age 4.5 to 6 years. Decreased LPS-stimulated Treg percentage was seen at age 6 years for high versus low farm-milk and animal-stable exposure (P = 0.045). There was a correlation for elevated LPS-stimulated Treg percentage at age 6 with increased risk of asthma (adjusted odds ratio, 11.29). Less efficient suppression of interferon gamma and interleukin-9 were seen for Tregs from asthmatics versus non-asthmatics. Between 4.5 and 6 years there was a decrease in mRNA expression of Th1/Th2/Th17-associated cell markers (P < 0.001).

"This immunological switch defines a critical 'time-window' for Treg-mediated asthma protection via environmental exposure before age 6 years," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »